Securing technology for treating and controlling new and variant viruses and multi-drug resistant superbacteria
The Department has contributed to public safety by securing technologies for controlling high-risk infectious diseases to resolve daily problems and social issues related to the citizens’ healthy life.
Director
NameSoo Bong Han
Office+82-42-860-7133
E-mailsbhan@krict.re.kr
Soo Bong Han
Research goals
Development of innovative technology for treating and controlling high-risk viruses
Development of innovative technology for treating and controlling high-risk bacteria
Major research fields
Development of therapeutics for chronic hepatitis B virus
Development of therapeutics for picornavirus
Development of candidates for Gram negative bacteria therapeutics
Establishment of HTS system for Gram negative bacteria and discovery of effective materials
Development of clinical candidates for new anti-viral drugs that can effectively treat COVID-19
Key research accomplishments
[Patent] Antiviral compound, preparation method thereof, and pharmaceutical composition for use in preventing or treating viral diseases containing the same as an active ingredient - 2019
[Patent] Quinazoline derivatives, preparation method thereof, and pharmaceutical composition for treating influenza virus containing the same – 2019
[Patent] Compound for the treatment of diseases caused by coronavirus infection – 2018
[Patent] Novel benzothiophene derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating viral diseases containing the same as an active ingredient –2018
[Patent] Tetrahydrobenzothiophene derivatives, preparation method thereof, and pharmaceutical composition for prevention or treatment of the viral diseases containing the same
[Patent] Novel compound or pharmaceutically acceptable salt thereof and pharmaceutical composition for prevention or treatment of disease caused by influenza virus infection containing the same as an active ingredient – 2017
Development of technology for simultaneously observe real-time behavior of label-free biomolecules, such as virus and bacteria, through various optical signals